Skip to main content
Masahiro Ono, MD, Thoracic Surgery, Austin, TX

MasahiroOnoMDPhD

Thoracic Surgery Austin, TX

Adult Cardiac Surgery, Cardiopulmonary Transplantation

University of Texas at Austin Dell Medical School

Dr. Ono is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ono's full profile

Already have an account?

  • Office

    1301 W 38th St Ste 307
    Austin, TX 78705
    Phone+1 512-324-3028

Summary

  • Dr. Masahiro Ono is a thoracic surgeon in Austin, TX and is affiliated with multiple hospitals in the area, including Ascension Seton Medical Center Austin. He also speaks multiple languages, including Japanese. He specializes in adult cardiac surgery and cardiopulmonary transplantation and is experienced in cardiogenic shock, ventricular assist device implantation, extracorporeal membrane oxygenation, adult cardiac surgery, and lung transplant surgery.

Education & Training

  • Texas Heart Institute
    Texas Heart InstituteFellowship, Thoracic Surgery, 2013 - 2016
  • Johns Hopkins University
    Johns Hopkins UniversityPost-Doctoral Fellowship, Thoracic Surgery, 2010 - 2013
  • Showa University School of Medicine
    Showa University School of MedicinePh.D., 2009

Certifications & Licensure

  • NM State Medical License
    NM State Medical License 2020 - 2026
  • TX State Medical License
    TX State Medical License 2019 - 2025

Awards, Honors, & Recognition

  • Branislav Radovancevic Memorial Fellowship Grant Award International Society for Heart & Lung Transplantation, 2013
  • 14th Annual ACCM Research Day Academic Award Johns Hopkins Hospital, 2012
  • 17th Annual Anselm Talalay Vincent Gott Cardiac Research Prize Winner Johns Hopkins Hospital, 2011
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Regional Heterogenelty of Cerebral Cortical Hemoglobin Concentrations Measured with Cerebral Optical Topography During Cardiac Surgery in Adults  
    Gottschalk A, Ono M, Hogue CW, Anesthesia and Analgesia, 1/1/2015
  • Rewarming Rate During Cardiopulmonary Bypass Is Associated with Release of Glial Fibrillary Acidicic Protein  
    Hori D, Everett AD, Lee JK, Ono M, Brown CH, Shah AS, Mandal K, Price JE, Lester LC, Hogue CW, Annals of Thoracic Surgery, 1/1/2015
  • Hypotension After Cardiac Operations Based on Autoregulation Monitoring Leads to Brain Cellular Injury  
    Hori D, Ono M, Rappold TE, Conte JV, Shah AS, Cameron DE, Adachi H, Everett AD, Hogue CW, Annals of Thoracic Surgery, 1/1/2015
  • Join now to see all

Abstracts/Posters

  • Individual Optimal Blood Pressure Determined by Cerebral Autoregulation Monitoring During and After Continuous-Flow Left Ventricular Assist Device Implantation
    Ono M, Singh SK, Kibler KK, Easley RB, Brady KM, 36th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation, Washington, DC, 1/27/2016
  • Preoperative Risk Factors for Stroke After HeartWare Left Ventricular Assist Device Implantation: Texas Heart Institute Experience
    Ono M, Singh SK, Cohn WE, Civitello AB, Frazier OH, 36th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation, Washington, DC, 1/27/2016
  • Optimal Blood Pressure during Cardiopulmonary Bypass defined by Cerebral Autoregulation Monitoring and its association with Severe Coronary Artery Disease
    Hori D, Nomura Y, Ono M, Joshi B, Mandal K, Cameron ED, Hogue CW, 96th Annual Meeting of the American Association for Thoracic Surgery, Baltimore, MD, 1/14/2016
  • Join now to see all

Lectures

  • Current LVAD state in USA and Texas Heart Institute 
    Tokyo, Japan - 1/1/2015
  • Cerebral Protection and Autoregulation during Cardiopulmonary Bypass - What Do We Not Know? 
    Brussels, Belgium - 1/1/2014

Press Mentions

  • Multi-Center, Multi-Society Study of Impella-Supported Patients with Cardiogenic Shock Due to Myocarditis in Japan Achieves 30-Day Survival of 77%
    Multi-Center, Multi-Society Study of Impella-Supported Patients with Cardiogenic Shock Due to Myocarditis in Japan Achieves 30-Day Survival of 77%September 20th, 2022
  • Triple Therapy Demonstrates 100% Cure Rate in Mouse Model of Melanoma
    Triple Therapy Demonstrates 100% Cure Rate in Mouse Model of MelanomaMay 26th, 2022
  • Auf Der STS-Jahrestagung Vorgestellte Umfangreiche Klinische Studie Zeigt Überlebensrate Von 79 % Bei Behandlung Mit Impella 5.5 Mit SmartAssist Herzpumpe
    Auf Der STS-Jahrestagung Vorgestellte Umfangreiche Klinische Studie Zeigt Überlebensrate Von 79 % Bei Behandlung Mit Impella 5.5 Mit SmartAssist HerzpumpeFebruary 1st, 2021
  • Join now to see all

Other Languages

  • Japanese